Barry Callebaut Valuation

BYCBF Stock  USD 1,450  50.00  3.33%   
At this time, the firm appears to be overvalued. Barry Callebaut AG shows a prevailing Real Value of $1218.0 per share. The current price of the firm is $1450.0. Our model approximates the value of Barry Callebaut AG from analyzing the firm fundamentals such as Current Valuation of 12.02 B, return on equity of 0.13, and Profit Margin of 0.04 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
1,450
Please note that Barry Callebaut's price fluctuation is very steady at this time. Calculation of the real value of Barry Callebaut AG is based on 3 months time horizon. Increasing Barry Callebaut's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Barry pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Barry Callebaut AG. Since Barry Callebaut is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Barry Pink Sheet. However, Barry Callebaut's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1450.0 Real  1218.0 Hype  1450.0 Naive  1620.51
The real value of Barry Pink Sheet, also known as its intrinsic value, is the underlying worth of Barry Callebaut AG Company, which is reflected in its stock price. It is based on Barry Callebaut's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Barry Callebaut's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
1,218
Real Value
1,595
Upside
Estimating the potential upside or downside of Barry Callebaut AG helps investors to forecast how Barry pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Barry Callebaut more accurately as focusing exclusively on Barry Callebaut's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1,3511,6872,023
Details
Hype
Prediction
LowEstimatedHigh
1,4471,4501,453
Details
Potential
Annual Dividend
LowForecastedHigh
9.179.349.51
Details

Barry Callebaut Total Value Analysis

Barry Callebaut AG is currently forecasted to have takeover price of 12.02 B with market capitalization of 11.6 B, debt of 1.3 B, and cash on hands of 732.57 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Barry Callebaut fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
12.02 B
11.6 B
1.3 B
732.57 M

Barry Callebaut Investor Information

About 36.0% of the company shares are held by company insiders. The book value of Barry Callebaut was currently reported as 529.7. The company has Price/Earnings To Growth (PEG) ratio of 1.92. Barry Callebaut AG recorded earning per share (EPS) of 71.18. The entity last dividend was issued on the 9th of January 2023. Based on the key indicators related to Barry Callebaut's liquidity, profitability, solvency, and operating efficiency, Barry Callebaut AG is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.

Barry Callebaut Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Barry Callebaut has an asset utilization ratio of 104.26 percent. This implies that the Company is making $1.04 for each dollar of assets. An increasing asset utilization means that Barry Callebaut AG is more efficient with each dollar of assets it utilizes for everyday operations.

Barry Callebaut Ownership Allocation

The market capitalization of Barry Callebaut AG is $11.6 Billion. Barry Callebaut AG retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.

Barry Callebaut Profitability Analysis

The company reported the revenue of 8.09 B. Net Income was 360.7 M with profit before overhead, payroll, taxes, and interest of 1.22 B.

Barry Callebaut Past Distributions to stockholders

Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Barry Callebaut's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Barry Callebaut and how it compares across the competition.

About Barry Callebaut Valuation

The pink sheet valuation mechanism determines Barry Callebaut's current worth on a weekly basis. Our valuation model uses a comparative analysis of Barry Callebaut. We calculate exposure to Barry Callebaut's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Barry Callebaut's related companies.
Barry Callebaut AG, together with its subsidiaries, manufactures and sells cocoa and chocolate products. Barry Callebaut AG was incorporated in 1994 and is headquartered in Zrich, Switzerland. Barry Callebaut is traded on OTC Exchange in the United States.

8 Steps to conduct Barry Callebaut's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Barry Callebaut's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Barry Callebaut's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Barry Callebaut's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Barry Callebaut's revenue streams: Identify Barry Callebaut's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Barry Callebaut's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Barry Callebaut's growth potential: Evaluate Barry Callebaut's management, business model, and growth potential.
  • Determine Barry Callebaut's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Barry Callebaut's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Barry Callebaut's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Barry Callebaut's value is low or high relative to the company's performance and growth projections. Determining the market value of Barry Callebaut can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Barry Callebaut represents a small ownership stake in the entity. As a stockholder of Barry, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Barry Callebaut Dividends Analysis For Valuation

Please note that Barry Callebaut has scaled down on payment of dividends at this time.
There are various types of dividends Barry Callebaut can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Barry shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Barry Callebaut AG directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Barry pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Barry Callebaut by the value of the dividends paid out.

Barry Callebaut Growth Indicators

Investing in growth stocks can be very risky. If the company such as Barry Callebaut does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding5.5 M
Quarterly Earnings Growth Y O Y-0.239
Forward Price Earnings20.4499
Retained Earnings3.8 B

Complementary Tools for Barry Pink Sheet analysis

When running Barry Callebaut's price analysis, check to measure Barry Callebaut's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Barry Callebaut is operating at the current time. Most of Barry Callebaut's value examination focuses on studying past and present price action to predict the probability of Barry Callebaut's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Barry Callebaut's price. Additionally, you may evaluate how the addition of Barry Callebaut to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Valuation
Check real value of public entities based on technical and fundamental data